Skip to main content
Article
A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia
British Journal of Haematology (2013)
  • Fabiana Ostronoff, Fred Hutchinson Cancer Research Center
  • Megan Othus, Fred Hutchinson Cancer Research Center
  • Hagop M. Kantarjian, University of Texas MD Anderson Cancer Center
  • Soheil Meshinchi, Fred Hutchinson Cancer Research Center
  • Farhad Ravandi, University of Texas MD Anderson Cancer Center
  • Paul C. Hendrie, University of Washington
  • Stefan Faderl, University of Texas MD Anderson Cancer Center
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Jorge E. Cortes, University of Texas MD Anderson Cancer Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • John E. Godwin, Southern Illinois University Carbondale
  • Cheryl L. Willman, University of New Mexico
  • Sherry A. Pierce, University of Texas MD Anderson Cancer Center
  • Alan F. List, University of South Florida
  • Ravinder K. Sandhu, Fred Hutchinson Cancer Research Center
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Derek L. Stirewalt, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Publication Date
January 10, 2013
DOI
10.1111/bjh.12450
Citation Information
Fabiana Ostronoff, Megan Othus, Hagop M. Kantarjian, Soheil Meshinchi, et al.. "A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia" British Journal of Haematology Vol. 163 Iss. 1 (2013) p. 130 - 132
Available at: http://works.bepress.com/john-pagel/129/